Drug Research
Biocair transports COVID-19 antibody tests for the German Football Association
As part of the agreement, Biocair will transport selected blood samples to specialist laboratories for investigation to find out if the individual has developed antibodies...
Drug Research
Thermo Fisher and Daiichi Sankyo to Co-Develop Global Companion Diagnostic for Patients with Non-Small Cell Lung Cancer
Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will utilize Thermo...
Drug Research
Piramal Pharma Announces Acquisition of Solid Oral Dosage Drug Product Facility in Pennsylvania from G&W Laboratories
Piramal Enterprises Limited’s (PEL) Pharma Solutions business, a contract development and manufacturing organization, has entered into an agreement with G&W Laboratories Inc. to acquire its...
Drug Research
Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced...
Drug Research
Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), produces a GMP-grade clinical batch of CALY-002 for Calypso Biotech. The immunotherapy biotech company retained...
Drug Research
Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, announced it has signed a supply agreement with AstraZeneca UK...
Drug Research
Neurocrine and Takeda Ink $2 Billion-Plus Neuroscience Development Deal
San Diego-based Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline. Takeda granted an exclusive license...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.